###begin article-title 0
###xml 89 94 <span type="species:ncbi:9606">Women</span>
Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women
###end article-title 0
###begin p 1
Conceived and designed the experiments: TRH DS SL AS AA WES LPPZ TMH. Performed the experiments: TRH MJ. Analyzed the data: TRH DS SL HW YY PLR MJ TMH. Wrote the paper: TRH DS SL HW YY PLR AS MJ AA WES LPPZ TMH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Although behavioral risk factors are strongly associated with urinary tract infection (UTI) risk, the role of genetics in acquiring this disease is poorly understood.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 182 187 <span type="species:ncbi:9606">women</span>
###xml 395 400 <span type="species:ncbi:9606">women</span>
To test the hypothesis that polymorphisms in Toll-like receptor (TLR) pathway genes are associated with susceptibility to UTIs, we conducted a population-based case-control study of women ages 18-49 years. We examined DNA variants in 9 TLR pathway genes in 431 recurrent cystitis (rUTI) cases, 400 pyelonephritis cases, and 430 controls with no history of UTIs. In the Caucasian subgroup of 987 women, polymorphism TLR4_A896G was associated with protection from rUTI, but not pyelonephritis, with an odds ratio (OR) of 0.54 and a 95% confidence interval (CI) of 0.31 to 0.96. Polymorphism TLR5_C1174T, which encodes a variant that abrogates flagellin-induced signaling, was associated with an increased risk of rUTI (OR(95%CI): 1.81 (1.00-3.08)), but not pyelonephritis. Polymorphism TLR1_G1805T was associated with protection from pyelonephritis (OR(95%CI): 0.53 (0.29-0.96)).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
These results provide the first evidence of associations of TLR5 and TLR1 variants with altered risks of acquiring rUTI and pyelonephritis, respectively. Although these data suggest that TLR polymorphisms are associated with adult susceptibility to UTIs, the statistical significance was modest and will require further study including validation with independent cohorts.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 425 428 425 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Foxman1">[1]</xref>
###xml 430 433 430 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ikaheimo1">[2]</xref>
###xml 815 818 815 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hooton1">[3]</xref>
###xml 820 823 820 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Scholes1">[4]</xref>
###xml 825 828 825 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Scholes2">[5]</xref>
###xml 61 66 <span type="species:ncbi:9606">women</span>
###xml 325 330 <span type="species:ncbi:9606">women</span>
###xml 376 381 <span type="species:ncbi:9606">women</span>
###xml 462 467 <span type="species:ncbi:9606">women</span>
###xml 844 849 <span type="species:ncbi:9606">women</span>
Acute uncomplicated urinary tract infections (UTIs) in young women are exceedingly common and result in substantial morbidity, time lost from work, and medical costs. Treatment requires the frequent use of antibiotics which contributes to drug resistance. Recurrent UTI (rUTI) is a common syndrome in otherwise young healthy women. Previous studies suggest that 27% to 44% of women who experience an initial UTI develop rUTI [1], [2]. The vast majority of these women do not have underlying functional or anatomic abnormalities of the urinary tract. Although pyelonephritis is less common than cystitis, it is a serious illness that can result in expensive hospitalization. Behavioral factors, such as sexual intercourse and spermicide use, are strongly associated with an increased risk of rUTI and pyelonephritis [3], [4], [5]. However, many women with uncomplicated UTI do not have obvious behavioral, functional or anatomic risk factors, suggesting that genetic risk factors may be present.
###end p 9
###begin p 10
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Casanova1">[6]</xref>
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Cooke1">[7]</xref>
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Sorensen1">[8]</xref>
###xml 346 349 346 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lundstedt1">[9]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hopkins1">[10]</xref>
###xml 612 615 612 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Scholes1">[4]</xref>
###xml 617 620 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Scholes2">[5]</xref>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hooton2">[11]</xref>
###xml 813 817 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Kinane1">[12]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Sheinfeld1">[13]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ishitoya1">[14]</xref>
###xml 831 835 831 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lomberg1">[15]</xref>
###xml 837 841 837 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Tomisawa1">[16]</xref>
###xml 964 968 964 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Artifoni1">[17]</xref>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lundstedt2">[18]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Tabel1">[19]</xref>
###xml 982 986 982 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Karoly1">[20]</xref>
###xml 1165 1169 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lundstedt2">[18]</xref>
###xml 1171 1175 1171 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Frendeus1">[21]</xref>
###xml 1177 1181 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ragnarsdottir1">[22]</xref>
###xml 1183 1187 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Smithson1">[23]</xref>
###xml 1262 1266 1262 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Frendeus1">[21]</xref>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 279 287 <span type="species:ncbi:9606">children</span>
###xml 424 429 <span type="species:ncbi:9606">women</span>
###xml 499 504 <span type="species:ncbi:9606">women</span>
###xml 862 870 <span type="species:ncbi:9606">children</span>
###xml 1189 1194 <span type="species:ncbi:10090">Mouse</span>
###xml 1331 1336 <span type="species:ncbi:9606">human</span>
A series of studies over several decades indicates that host genetic factors influence susceptibility to human infections [6], [7], [8]. More recent studies suggest an influence of genetics on susceptibility to UTIs. In one family study, 15% of relatives of pyelonephritis-prone children had a UTI history compared to 3% of relatives of controls [9]. In adults, 65.5% of mothers, 60.7% of daughters, and 48.6% of sisters of women with rUTI had a similar history [10]. We previously found that adult women with rUTI or pyelonephritis were more likely to have a mother with a UTI history in comparison to controls [4], [5]. Aside from associations of non-secretor blood group antigens and P1 phenotype with RUTI and/or pyelonephritis, we are not aware of any associations of polymorphisms with UTIs in adults [11], [12], [13], [14], [15], [16]. Genetic studies in children have reported associations of polymorphisms in CXCR1, TLR2, and TLR4 with UTI susceptibility [17], [18], [19], [20]. In addition, reduced expression levels of CXCR1, CXCR2 and TLR4 on neutrophils was associated with pyelonephritis, recurrent cystitis and asymptomatic bacteriuria, respectively [18], [21], [22], [23]. Mouse studies have also suggested a role for CXCR1 in UTI susceptibility [21]. Although these studies suggest a possible role for genetics in human UTI susceptibility, the genes involved remain largely unknown.
###end p 10
###begin p 11
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Akira1">[24]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Beutler1">[25]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Medzhitov1">[26]</xref>
###xml 428 432 428 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Mulvey1">[27]</xref>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lane1">[28]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Backhed1">[29]</xref>
###xml 701 708 701 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 818 822 818 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Akira1">[24]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Beutler1">[25]</xref>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Medzhitov1">[26]</xref>
###xml 1026 1030 1026 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-AndersenNissen1">[30]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Shahin1">[31]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Svanborg1">[32]</xref>
###xml 1044 1048 1044 1048 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Zhang1">[33]</xref>
###xml 688 694 <span type="species:ncbi:9606">humans</span>
###xml 701 708 <span type="species:ncbi:562">E. coli</span>
###xml 865 869 <span type="species:ncbi:10090">mice</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
Toll-like receptors (TLRs) are a family of germline-encoded receptors that orchestrate the innate immune response and recognize Pathogen-Associated Molecular Patterns (PAMPs) such as bacterial flagellin (TLR5), lipopolysaccharide (LPS) (TLR4), and bacterial lipopeptides (TLR1/2/6) [24], [25], [26]. During a UTI, bacteria colonize the urethra and ascend to the bladder, where they can persist at high levels and cause cystitis [27]. In addition, pathogens may ascend to the kidney and cause serious complications, including pyelonephritis and bacteremia [28]. The initial recognition of bacteria occurs at the epithelial cell surface of the urogenital tract, a site of TLR expression in humans [29]. E. coli, which causes 70-90% of all uncomplicated UTIs, is recognized by several TLRs, including TLR1,2,4,5,6 and 11 [24], [25], [26]. Although previous studies in mice indicate that TLR4, TLR5, and TLR11 regulate susceptibility to cystitis and pyelonephritis, the role of TLRs in human UTI pathogenesis is poorly understood [30], [31], [32], [33].
###end p 11
###begin p 12
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Arbour1">[34]</xref>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn1">[35]</xref>
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn2">[36]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn3">[37]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Johnson1">[38]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Khor1">[39]</xref>
###xml 191 195 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch1">[40]</xref>
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch2">[41]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Schroder1">[42]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Wurfel1">[43]</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Tabel1">[19]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Karoly1">[20]</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 345 353 <span type="species:ncbi:9606">children</span>
###xml 798 803 <span type="species:ncbi:9606">women</span>
We and others have characterized human TLR pathway polymorphisms that are associated with altered gene function and susceptibility to different infections [34], [35], [36], [37], [38], [39], [40], [41], [42], [43]. Although two previous studies suggest that polymorphisms TLR2_G2258A and TLR4_A896G are associated with susceptibility to UTIs in children, the role of the other functionally significant TLR polymorphisms in UTI pathogenesis is not currently known [19], [20]. In addition, it is also not known whether any TLR variants are associated with cystitis or pyelonephritis in adults. In this manuscript, we summarize the results of a population-based case-control study examining whether polymorphisms in TLR genes are associated with susceptibility to cystitis and pyelonephritis in adult women ages 18-49 years.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
###xml 18 30 <span type="species:ncbi:9606">Participants</span>
Study Setting and Participants
###end title 14
###begin p 15
###xml 693 694 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1052 1053 1048 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 41 46 <span type="species:ncbi:9606">Human</span>
###xml 1171 1176 <span type="species:ncbi:9606">women</span>
The study protocols were approved by the Human Subjects committees at Group Health Cooperative, the University of Washington, and Western Institutional Review Board. The study was conducted at Group Health Cooperative in Seattle, Washington. We selected potential RUTI and pyelonephritis cases from the health plan's automated databases. Potential cystitis subjects were identified through having received an International Classification of Diseases (ICD-9) diagnosis code. Recurrent cystitis (rUTI) case subjects were identified based on 3 diagnosed UTI episodes within a 12-month time frame or 2 UTIs within 6 months (episodes were separated by at least 30 days). Culture confirmation (>/=103 cfu/mL of a urinary pathogen) or UTI guideline-related treatment was required for all UTI episodes in the cluster. Potential pyelonephritis subjects were identified through having received a pyelonephritis ICD-9 diagnosis code and, if they received only outpatient treatment, a primary diagnosis of pyelonephritis and an accompanying culture result of >/=103 cfu/mL of a urinary pathogen or accompanying antibiotic therapy appropriate for pyelonephritis. The remainder of the women in the registries constituted the potential control subjects who were randomly selected and frequency-matched by case age group (age categories were 18-29, 30-39, 40-49 years).
###end p 15
###begin p 16
###xml 10 22 <span type="species:ncbi:9606">participants</span>
###xml 193 205 <span type="species:ncbi:9606">participants</span>
###xml 570 575 <span type="species:ncbi:9606">Women</span>
###xml 936 941 <span type="species:ncbi:9606">women</span>
###xml 1043 1048 <span type="species:ncbi:9606">women</span>
###xml 1096 1108 <span type="species:ncbi:9606">participants</span>
###xml 1123 1128 <span type="species:ncbi:9606">women</span>
###xml 1328 1333 <span type="species:ncbi:9606">women</span>
###xml 1348 1353 <span type="species:ncbi:9606">women</span>
###xml 1517 1522 <span type="species:ncbi:9606">women</span>
###xml 1557 1562 <span type="species:ncbi:9606">women</span>
Potential participants received a letter of invitation describing the study and inviting their participation. In screening for eligibility, exclusion criteria were kept to a minimum. Potential participants were queried as to whether they could urinate on their own and were ambulatory. In addition, potential control subjects were asked about previous UTIs and were excluded if they reported previous healthcare provider-diagnosed cystitis episodes. If they reported a history of pyelonephritis or kidney infections, they were enrolled in the pyelonephritis case group. Women who were eligible and willing to take part in the study were scheduled for a clinic visit where case histories of recurrent cystitis and/or pyelonephritis were confirmed. The number of lifetime UTIs was determined by self-reporting. For controls, we verified that they had no history of UTIs. Ethnicity was determined by self-identification. We identified 877 women as potential rUTI subjects, 673 as potential pyelonephritis subjects, and 1,923 as potential control women during recruitment. Of the potential rUTI case participants, 431 (59%) of women identified as eligible agreed to participate and completed their clinic appointments; 144 were identified as ineligible; 256 refused; and 46 could not be reached. Among potential pyelonephritis case women, 400 (69%) of women identified as eligible agreed and completed clinic appointments; 89 were ineligible; 155 refused; and 29 could not be reached. Of the identified potential control women, 430 (47%) of identified eligible women agreed and made clinic visits; 999 were ineligible, due in large part to having a history of cystitis; 440 refused; and 54 could not be reached.
###end p 16
###begin title 17
Genomic techniques
###end title 17
###begin p 18
###xml 911 915 911 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Gordon1">[44]</xref>
###xml 1317 1321 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Liu1">[45]</xref>
###xml 1422 1426 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn4">[46]</xref>
###xml 1428 1432 1419 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Storm1">[47]</xref>
Genomic DNA was purified from peripheral blood by QIAamp DNA blood kit (Qiagen). For TLR2, 4, 5, MYD88 (Myeloid differentiation primary response gene 88), TIRAP/MAL (TIR domain containing adapter/MYD88 adaptor-like), TICAM1/TRIF (TIR-Domain-containing adaptor molecule 1/TIR domain-containing adaptor inducing interferon beta), and TRAM (TRIF-related adaptor molecule), we sequenced the coding region to look for polymorphisms. We attempted to sequence 48 or 96 samples per gene depending on levels of previous investigations. We obtained high quality sequence of the entire coding region in 45 subjects for TLR2, 43 for TLR4, 46 for TLR5, 86 for TIRAP, and 87 for TRIF. We amplified the coding region by PCR, sequenced it with Big Dye Terminator v3.0 and then analyzed it on an ABI PRISM 3730 capillary sequencer (Applied Biosystems). Sequence was aligned and analyzed with the programs PHRED/PHRAP and CONSED [44]. For genotyping in the full cohort, we generated haplotype tagging SNPs from our sequencing data as well as publicly available data from the Innate Immunity Program in Genomic Applications (IIPGA, ). For determining haplotype tagging SNPs, we used a multilocus linkage disequilibrium measure based on generalized mutual information,which is also known as relative entropy or Kullback-Leibler distance [45]. Genotyping was carried out with a MassARRAYtrade mark technique (Sequenom) as previously described [46], [47].
###end p 18
###begin title 19
Statistical Analyses
###end title 19
###begin p 20
###xml 796 800 796 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Zhao1">[48]</xref>
###xml 1525 1529 1523 1527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Zhao1">[48]</xref>
We evaluated the associations of case-control status (the outcome) and SNP genotypes under log-additive, recessive, and dominant models. In the log-additive model (also called an allelic trend test), common homozygous genotypes (00) were assigned a value of 0, heterozygotes (01) a value of 1, and minor homozygous genotypes (11) a value of 2. Odds ratios and significance levels were then assessed using a logistic regression model. For the dominant model analysis, we combined genotypes 01 and 11 and compared to genotype 00. For the recessive model, we compared genotypes 00 and 01 versus genotype 11. We also evaluated the association of case-control status with haplotypes of SNPs in constructed with an Expectation/Maximization (EM) algorithm with the program HPlus as previously described [48]. We analyzed the rUTI and pyelonephritis cases separately and in combination. Two-sided testing was used for all comparisons to evaluate statistical significance, considering a P-value of </=0.05 as significant. We evaluated the associations of SNPs with UTI intensity using a linear regression model for each case group and combined case groups. The coefficient with respect to SNP represents increased/decreased UTI intensity. The significance of coefficient measures the strength of the association of SNP genotypes with UTI intensity. To verify that our significant findings were not due to population admixture, we also performed Caucasian subgroup analyses. All analyses were performed using the software Hplus or SAS [48]. Hardy-Weinberg equilibrium (HWE) testing was performed for all SNP genotypes using Haploview. Except for minor deviations, all SNP genotypes satisfied Hardy-Weinberg in the Caucasian control group.
###end p 20
###begin title 21
Results
###end title 21
###begin title 22
TLR polymorphism discovery
###end title 22
###begin p 23
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t001">Table 1</xref>
###xml 423 430 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 175 180 <span type="species:ncbi:9606">women</span>
###xml 423 430 <span type="species:ncbi:562">E. coli</span>
###xml 1128 1133 <span type="species:ncbi:9606">women</span>
We used a case-control study design to examine whether TLR pathway gene polymorphisms were associated with susceptibility to recurrent cystitis and/or pyelonephritis in adult women. Cases and controls had a similar mean age and ethnic composition and were generally healthy with minimal co-morbid conditions (Table 1). We selected 9 genes for analysis, including TLRs 1, 2, 4, 5, 6 due to their central role in recognizing E. coli and other UTI-associated pathogens. We also chose to examine the adaptor molecules associated with these TLRs, including MYD88, TIRAP, TRIF, and TRAM. In order to discover novel polymorphisms associated with UTIs, we PCR-amplified and sequenced the coding regions of 7 TLR pathway genes (TLR2, TLR4, TLR5, MYD88, TIRAP, TRIF, and TRAM) in subjects with a high frequency of cystitis or pyelonephritis episodes. We did not discover any polymorphisms at >2% frequency in MYD88 or TRAM, so these genes were not studied further. We discovered previously reported polymorphisms in TLR2 (n = 45 subjects), TLR4 (n = 43), TIRAP (n = 86), and TRIF (n = 87) in this study population. In TLR5, among 46 case women, we found several previously reported polymorphisms as well as two novel SNPs (C541A (Q181K), ss136261639 in the NCBI dbSNP database () in 4/46 and A2254G (R752G), ss136261646 in 1/40). Together, the results for these 5 genes suggest that nearly all polymorphisms were previously available in public databases for genotyping strategies.
###end p 23
###begin title 24
Characteristics of Cases and Controls.
###end title 24
###begin p 25
Numbers and percentages in ethnicity subcategories can be greater than total number due to selection of more than one category for an individual.
###end p 25
###begin p 26
###xml 460 464 460 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Arbour1">[34]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn1">[35]</xref>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn2">[36]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn3">[37]</xref>
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Johnson1">[38]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Khor1">[39]</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch1">[40]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch2">[41]</xref>
###xml 508 512 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Schroder1">[42]</xref>
###xml 514 518 514 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Wurfel1">[43]</xref>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn2">[36]</xref>
###xml 995 1003 995 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Tables 2</xref>
###xml 1004 1005 1004 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t003">3</xref>
###xml 1046 1054 1046 1054 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t001">Tables 1</xref>
###xml 1059 1060 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">2</xref>
###xml 1315 1322 1315 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t001">Table 1</xref>
For our primary analysis, we examined whether 7 well-characterized TLR-pathway SNPs were associated with UTIs. Previous studies suggest that these SNPs are associated with altered TLR gene function and susceptibility to different infections. The polymorphisms include TLR1_G1805T (amino acid (AA) change S602I), TLR2_G2258A (AA R753Q), TLR4_A896G (AA D299G), TLR4_C1196T (AA T399I), TLR5_C1174T (AA R392STOP), TIRAP_C539T (AAS180L), and TIRAP_C558T (AA A186A) [34], [35], [36], [37], [38], [39], [40], [41], [42], [43]. Although TIRAP_C558T is a synonymous SNP, we have previously shown that it is associated with altered cytokine production in response to PAM2 stimulation [36]. We compared allele and genotype frequencies between cases and controls and found associations between SNPs TLR5_C1174T, TLR4_A896G, and TLR1_G1805T with UTI outcomes. Due to the presence of population heterogeneity in the entire cohort, we analyzed data in both the Caucasian subgroup as well as the entire cohort (Tables 2-3 for Caucasian subgroup and Supplemental Tables 1 and 2 for the entire cohort). The ethnic composition of the case and control populations was similar with a predominance of a Caucasian background in all groups (Caucasian frequency of 78.7% in RUTI cases, 80.3% in pyelonephritis cases, and 73.7% in controls, Table 1).
###end p 26
###begin title 27
Genotypic Analysis of Functional TLR SNPs in Caucasian Subgroup.
###end title 27
###begin p 28
P-value<0.05 is in bold.
###end p 28
###begin title 29
TLR Polymorphisms & Association with UTI Disease Status in Caucasian Subgroup.
###end title 29
###begin p 30
For coding region SNPs, the name includes nucleotide numbering based on mRNA with start codon at 1. For non-coding region SNPs, the name is from the IIPGA database () and designated with a "z" prefix. rs numbers from the dbSNP database are included when available. A log-additive model was used for analysis. P values</=0.05 in bold.
###end p 30
###begin p 31
HWE = Hardy Weinberg Equilibrium P value, a value>0.001 indicates that polymorphism is in Hardy-Weinberg Equilibrium.
###end p 31
###begin title 32
TLR1_G1805T is associated with protection from pyelonephritis
###end title 32
###begin p 33
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn3">[37]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Johnson1">[38]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Wurfel1">[43]</xref>
###xml 337 344 337 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 725 732 725 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 1027 1035 1027 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005990.s001">Table S1</xref>
We and others previously demonstrated that allele TLR1_1805G is associated with deficient TLR1 signaling in comparison to1805T[37], [38], [43]. We compared genotype frequencies in case and control groups and found that TLR1_1805T was associated with protection from UTIs in the combined rUTI and pyelonephritis case group in Caucasians (Table 2 log-additive model, OR(95%CI): 0.72 (0.53-0.97)). Functionally, we previously found that alleles G and T are co-dominant and that genotype 1805TT mediates higher levels of signaling than 1805GG with a mid-range level in 1805GT genotypes. In this study, we found that genotype 1805TT was associated with protection from pyelonephritis in comparison to the 1805GT and GG genotypes (Table 2, recessive model, OR(95%CI): 0.53 (0.29-0.96)). We next examined whether our results were influenced by effects of population heterogeneity. We found similar associations in the entire cohort with a protective effect of the 1805TT genotype seen when comparing controls to pyelonephritis cases (Table S1, OR(95%CI): 0.66 (0.47-0.93)).
###end p 33
###begin title 34
TLR4_A896G is associated with protection from rUTI
###end title 34
###begin p 35
###xml 164 171 164 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 457 464 457 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 549 557 549 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005990.s001">Table S1</xref>
Allele TLR4_896G has been associated with altered signaling in response to LPS in some studies. In our study, allele 896G was associated with protection from rUTI (Table 2, log-additive model, OR(95%CI) 0.54 (0.31-0.96)), but not pyelonephritis in the Caucasian subgroup. We also examined the genotype frequencies using a dominant effect model and found that genotypes 896AG/GG were associated with protection from rUTI when compared to the 896GG genotype (Table 2, OR(95%CI): 0.54 (0.32-0.96)). A similar association was seen in the entire cohort (Table S1, log-additive model OR(95%CI) 0.60 (0.38-0.96)), These results suggest that TLR4_A896G is associated with protection from rUTI, but not pyelonephritis.
###end p 35
###begin title 36
TLR5_C1174T is associated with increased susceptibility to rUTI
###end title 36
###begin p 37
###xml 68 69 68 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn1">[35]</xref>
###xml 552 559 552 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 926 934 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005990.s001">Table S1</xref>
###xml 315 320 <span type="species:ncbi:9606">women</span>
###xml 374 379 <span type="species:ncbi:9606">women</span>
###xml 810 815 <span type="species:ncbi:9606">women</span>
We next compared genotype frequencies in case and control groups of polymorphism TLR5_C1174T, which encodes a stop codon polymorphism that abrogates flagellin signaling. We previously demonstrated that allele T acts in a dominant fashion with respect to allele C [35]. The CT and TT gentoype frequencies of control women were 0.068 and 0.008, respectively, in comparison to women with rUTI who had frequencies of 0.122 and 0.003, respectively. These differences were statistically significant when comparing genotype frequencies with a dominant model (Table 2 dominant model, OR(95%CI): 1.81 (1.00-3.08)). A similar trend was observed in the log-additive model that did not reach statistical significance (OR(95%CI): 1.65 (0.89-3.05)). In contrast, no differences were seen when comparing 1174T frequencies in women with pyelonephritis versus controls. The entire cohort showed a similar association in the genotype analysis (Table S1 dominant model, OR(95%CI): 1.69 (1.06-2.70)). These results indicated that TLR5-deficiency is associated with increased susceptibility to rUTI, but not pyelonephritis. Together, these data provide evidence that SNPs TLR1_G1805T, TLR4_A896G, and TLR5_C1174T are associated with an altered risk of UTIs. However, the magnitude of the effect and the statistical significance were modest.
###end p 37
###begin p 38
###xml 112 119 112 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t002">Table 2</xref>
###xml 628 635 628 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t003">Table 3</xref>
###xml 640 648 640 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005990.s002">Table S2</xref>
###xml 897 904 897 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t003">Table 3</xref>
###xml 909 917 909 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005990.s002">Table S2</xref>
None of the other functional TLR SNPs were associated with UTI susceptibility in allelic or genotypic analyses (Table 2). We also generated haplotype tagging SNPs for TLRs 2, 4, 5, TIRAP, and TRIF from our sequencing data as well as TLR1 and 6 from public databases (Innate Immunity Programs for Genomic Applications database ()). We derived 46 haplotype tagging SNPs, including the 7 functional SNPs that had been initially analyzed. We examined whether the genotype and haplotype frequencies of these polymorphisms differed in the pyelonephritis or rUTI case groups in comparison to the control group with no history of UTIs (Table 3 and Table S2). In this group of TLR pathway polymorphisms, there were occasional SNPs with associations with UTI risk, but they were no polymorphisms with known function, of a large magnitude, of high statistical significance, or clustered within single genes (Table 3 and Table S2, see SNPs TLR1_T130C, TLR4_zA11547G, and TRIF_C1671T). We also examined TLR1, TLR4, and TLR5 haplotypes to determine whether other SNPs in these genes modified the association with UTI susceptibility. We did not find any stronger associations within haplotypes to suggest additive or synergistic associations when the alleles were examined together (data not shown).
###end p 38
###begin title 39
TLR Polymorphisms & UTI Disease Intensity
###end title 39
###begin p 40
###xml 367 374 367 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t004">Table 4</xref>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005990-t004">Table 4</xref>
We next examined whether SNPs TLR1_G1805T, TLR4_A896G, and TLR5_C1174T are associated with UTI disease intensity (expressed as the number of lifetime UTIs divided by age). Allele TLR5_1174T was associated with an increased number of rUTI episodes in the allelic (coefficient 0.29, P = 0.018) and genotypic analysis (dominant comparison, coefficient 0.31, P = 0.018) (Table 4). Allele 896G was associated with a decreased number of UTI episodes in the combined case group (coefficient -0.34, P = 0.011) and pyelonephritis group (coefficient -0.47, P = 0.033) (Table 4). Similar associations were found with the genotypic analysis (dominant comparison, combined case group coefficient -0.33 (P = 0.020) and pyelonephritis coefficient -0.50 (P = 0.027)). Together, these results suggest that SNPs TLR5_C1174T and TLR4_A896G are associated with altered UTI disease intensity as well as disease susceptibility.
###end p 40
###begin title 41
Analysis of 3 Functional TLR SNPs with UTI Disease Intensity.
###end title 41
###begin p 42
Coefficient represents increase/decrease (positive/negative) in number of lifetime UTIs divided by age for each variant allele.
###end p 42
###begin p 43
Coefficient represents the difference in number of lifetime UTIs divided by age between the comparison groups.
###end p 43
###begin p 44
Recessive model comparison is unreliable due to small numbers of minor allele homozygotes.
###end p 44
###begin p 45
P values</=0.05 in bold.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 599 606 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 970 977 970 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 599 606 <span type="species:ncbi:562">E. coli</span>
###xml 970 977 <span type="species:ncbi:562">E. coli</span>
In these analyses, we examined whether polymorphisms from the TLR pathway are associated with susceptibility to serious and recurrent UTI. The major findings of our study were that SNP TLR5_C1174T was associated with increased susceptibility to RUTI, SNP TLR4_A896G was associated with protection from RUTI, and SNP TLR1_G1805T was associated with protection from pyelonephritis. There are several possible mechanisms by which TLRs might affect the pathogenesis of cystitis and pyelonephritis. If bladder and kidney epithelial cells have a TLR-mediated signaling defect, then initial recognition of E. coli would be impaired and activation of signaling pathways might be delayed. In addition, neutrophils or monocytes that are recruited to the bladder might have altered responses and result in greater susceptibility to UTIs. Alternatively, or in addition, TLRs may regulate dendritic cell maturation and influence the activation and maintenance of T cell responses to E. coli antigens.
###end p 47
###begin p 48
###xml 177 185 177 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 252 259 252 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 306 310 306 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch1">[40]</xref>
###xml 645 649 645 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn1">[35]</xref>
###xml 823 827 823 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hawn3">[37]</xref>
###xml 829 833 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Johnson1">[38]</xref>
###xml 835 839 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Misch2">[41]</xref>
###xml 841 845 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Wurfel1">[43]</xref>
###xml 1132 1136 1132 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Johnson1">[38]</xref>
###xml 1206 1210 1206 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Wurfel1">[43]</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ma1">[49]</xref>
###xml 1257 1264 1257 1264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1296 1324 1296 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus saprophyticus</italic>
###xml 1330 1337 1330 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proteus</italic>
###xml 1339 1351 1339 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterobacter</italic>
###xml 1353 1363 1353 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Klebsiella</italic>
###xml 1365 1376 1365 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pseudomonas</italic>
###xml 1382 1394 1382 1394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus</italic>
###xml 1257 1264 <span type="species:ncbi:562">E. coli</span>
###xml 1296 1324 <span type="species:ncbi:29385">Staphylococcus saprophyticus</span>
Previous studies have demonstrated that each of these 3 polymorphisms regulates signaling at the molecular and cellular level. SNP TLR4_A896G has been associated with decreased in vitro signaling in response to LPS in some studies as well as decreased in vivo bronchial airway responsiveness. (reviewed in [40]). Other studies did not find a difference in signaling and suggested that any functional alteration may be dependent on the assay conditions. We previously described that SNP TLR5_C1174T, which encodes a stop codon polymorphism, abolishes flagellin signalling, and is associated with increased susceptibility to Legionnaires' Disease [35]. More recently, we and others discovered that SNP TLR1_T1805G is associated with deficient TLR1 signaling as well as susceptibility to leprosy and leprosy reversal reaction [37], [38], [41], [43]. Cells from 1805TT individuals secrete 5-10 fold greater amounts of IL-6 than 1805GG cells when stimulated with PAM3, a TLR1 ligand. Intriguingly, Johnson et al also found that the TLR1 signaling defect is due to a complete absence of TLR1 on the surface of monocytes in GG individuals [38]. Recent studies have found associations with tuberculosis and sepsis [43], [49]. Greater than 80% of UTIs are caused by E. coli with other pathogens including Staphylococcus saprophyticus, and Proteus, Enterobacter, Klebsiella, Pseudomonas, and Enterococcus species. Each of these pathogens are known or predicted to contain cell wall lipopeptides, which are the classical ligands for TLR1-TLR2 activation.
###end p 48
###begin p 49
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hooton2">[11]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Kinane1">[12]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Sheinfeld1">[13]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ishitoya1">[14]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lomberg1">[15]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Tomisawa1">[16]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Artifoni1">[17]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Lundstedt2">[18]</xref>
###xml 876 880 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Tabel1">[19]</xref>
###xml 882 886 882 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Karoly1">[20]</xref>
###xml 1025 1029 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Ragnarsdottir1">[22]</xref>
###xml 521 529 <span type="species:ncbi:9606">children</span>
###xml 719 727 <span type="species:ncbi:9606">children</span>
###xml 840 846 <span type="species:ncbi:9103">Turkey</span>
###xml 963 968 <span type="species:ncbi:9606">women</span>
###xml 1363 1369 <span type="species:ncbi:9103">Turkey</span>
Although numerous studies have consistently documented several behavioral risk factors for acquiring urinary tract infections, accumulating evidence suggests that genetic factors are also important. Aside from associations of non-secretor blood group antigens and P1 phenotype with RUTI and/or pyelonephritis, we are not aware of any other associations of polymorphisms with UTIs in adults [11], [12], [13], [14], [15], [16]. Several studies to date have reported associations of polymorphisms with UTI susceptibility in children. Two separate studies reported associations of CXCR1 variants with pyelonephritis [17], [18]. Karoly et al found an association of SNP TLR4 A896G with an increased risk of UTI in Hungarian children (103 cases and 235 controls) and Tabel et al found that TLR2 SNP G2258A (R753Q) was associated with UTI risk in Turkey (124 cases and 116 controls) [19], [20]. In addition, reduced levels of TLR4 expression on neutrophils was found in women with asymptomatic bacteriuria in comparison to controls [22]. Our TLR4 findings showed an opposite effect in comparison to the Karoly study. Possible explanations for the lack of confirmation of the TLR2 and TLR4 findings in our study include differences in age (pediatric vs adult), ethnicity, and polymorphism frequency (frequency of G2258A was 2% in our population in comparison to 5-13% in Turkey). It is intriguing that two genetic UTI studies have identified associations of TLRs involved in lipopeptide recognition (TLR2 and TLR1) and independently suggest an important role for this pathway in UTI pathogenesis.
###end p 49
###begin p 50
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Price1">[50]</xref>
###xml 1033 1041 1033 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a priori</italic>
###xml 329 341 <span type="species:ncbi:9606">participants</span>
Our study has several strengths and weaknesses. Potential weaknesses include effects of population admixture and multiple comparisons. To account for possible confounding effects from population heterogeneity, we performed our analyses in the Caucasian subgroup as well as the entire cohort. In addition, we enrolled our control participants from the same defined population as the cases, thus minimizing biases that might arise from a more opportunistic source of controls. Despite these attempts to minimize population admixture effects, we cannot exclude this possibility. For example, recent studies of the ancestry of European Americans indicates population substructures that could be a source of admixture [50]. This issue can be most convincingly addressed by validation of these findings in an independent study. A second possible limitation is the issue of multiple comparisons. SNPs with well-characterized function do not generally have the same requirement for adjustments for multiple comparisons due to a well-founded a priori hypothesis of their potential association with a cellular function. As a matter of hypothesis testing, we prioritized seven well-characterized functional polymorphisms in our primary analysis. From these seven tests, we identified three significant associations and arguably no adjustments are necessary. As a secondary analysis, we genotyped an additional 39 SNPs to determine whether haplotypes containing the 7 functional SNPs were associated with outcome. If a strict Bonferroni correction were taken, none of them would survive adjustment for multiple comparisons after multiplying the observed P values by seven or 46. However, a Bonferroni correction is arguably too stringent in this context. Although haplotype tagging polymorphisms are deliberately selected to have low levels of pairwise linkage disequilibrium, we also included additional SNPs identified in the sequencing of the coding region. The SNPs within each gene had low levels of linkage disequilibrium and were thus not fully independent tests. An alternative adjustment would be to use a False Discovery Rate method which estimates the likelihood that our findings are false. By this method, the chance of falsely observing three significant tests out of seven is quite low at approximately 11.6% (7x0.05/3). Regardless of which adjustments are chosen for our data, convincing evidence of a genetic effect ultimately requires multiple replication studies as well as detailed analysis of functional effects of each polymorphism.
###end p 50
###begin p 51
Our study also had numerous strengths. First, to our knowledge this is the largest study to examine gene polymorphisms and UTI susceptibility and is the only study to date to examine this phenotype in adults. Second, to avoid a possible bias from age, we frequency matched controls to cases by age group to insure that there was similar exposure time for the development of UTIs. Finally, we enrolled subjects in a well-characterized population and verified diagnoses identified through automated indices with a clinic visit to collect additional clinical history.
###end p 51
###begin p 52
###xml 350 357 350 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-AndersenNissen1">[30]</xref>
###xml 543 550 543 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Shahin1">[31]</xref>
###xml 634 638 634 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hagberg1">[51]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hopkins2">[52]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Samuelsson1">[53]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Hedlund1">[54]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Jerde1">[55]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Schilling1">[56]</xref>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-Stein1">[57]</xref>
###xml 864 871 864 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005990-AndersenNissen1">[30]</xref>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 350 357 <span type="species:ncbi:562">E. coli</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 543 550 <span type="species:ncbi:562">E. coli</span>
###xml 824 830 <span type="species:ncbi:10090">murine</span>
Our findings raise several mechanistic questions about the role of different TLRs in UTI pathogenesis and how their effect differs for cystitis and pyelonephritis risk. Expression of individual TLRs varies in different genitourinary tissues. We previously demonstrated in a mouse model that TLR5 plays a crucial role in host defense to uropathogenic E. coli by limiting bacterial replication in both the bladder and kidney [30]. Other investigators have demonstrated that TLR4-deficient C3H/HeJ mice exhibit a reduced inflammatory response to E. coli and exhibit significantly higher bacterial counts in the bladder and kidneys [31], [51], [52]. Although TLR4 is expressed on urinary epithelium, there is conflicting evidence about whether the epithelial cells respond to LPS [53], [54], [55], [56], [57]. We found that the murine bladder was highly responsive to in vivo injection of flagellin, but relatively unresponsive to highly purified LPS [30]. These experiments suggest that TLR5 and TLR4 mediate distinct bladder innate immune responses with TLR5 regulating a relatively dominant role initially.
###end p 52
###begin p 53
###xml 140 145 <span type="species:ncbi:9606">women</span>
In summary, our results suggest that well-characterized polymorphisms in TLRs 1, 4, and 5 are associated with altered risks of UTI in adult women. Our work, along with others, contributes to an increased understanding of the importance of genetic variants that, along with behavioral risk factors, influence UTI susceptibility.
###end p 53
###begin title 54
Supporting Information
###end title 54
###begin p 55
(0.07 MB DOC)
###end p 55
###begin p 56
Click here for additional data file.
###end p 56
###begin p 57
(0.06 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
We thank Patricia Yarbro, Jane Grafton, Kelli O'Hara, Linda Wehnes, Holly Roberts, and Robin Gosney at Group Health for project management, programming, recruitment, and data collection and tracking. We also thank Carey Cassidy, Marsha Cox, Sarah Li, Sheila Manuguid, Rick Wells, and Yulia Yarova-Yarovaya for technical assistance and Richard Laws for database assistance.
###end p 59
###begin title 60
References
###end title 60
###begin article-title 61
Recurring urinary tract infection: incidence and risk factors.
###end article-title 61
###begin article-title 62
###xml 103 108 <span type="species:ncbi:9606">women</span>
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women.
###end article-title 62
###begin article-title 63
###xml 85 90 <span type="species:ncbi:9606">women</span>
A prospective study of risk factors for symptomatic urinary tract infection in young women.
###end article-title 63
###begin article-title 64
###xml 60 65 <span type="species:ncbi:9606">women</span>
Risk factors for recurrent urinary tract infection in young women.
###end article-title 64
###begin article-title 65
###xml 61 66 <span type="species:ncbi:9606">women</span>
Risk factors associated with acute pyelonephritis in healthy women.
###end article-title 65
###begin article-title 66
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human model: a genetic dissection of immunity to infection in natural conditions.
###end article-title 66
###begin article-title 67
###xml 30 35 <span type="species:ncbi:9606">human</span>
Genetics of susceptibility to human infectious disease.
###end article-title 67
###begin article-title 68
Genetic and environmental influences on premature death in adult adoptees.
###end article-title 68
###begin article-title 69
Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.
###end article-title 69
###begin article-title 70
###xml 81 86 <span type="species:ncbi:9606">women</span>
Evaluation of a familial predisposition to recurrent urinary tract infections in women.
###end article-title 70
###begin article-title 71
Effects of recent sexual activity and use of a diaphragm on the vaginal microflora.
###end article-title 71
###begin article-title 72
###xml 92 97 <span type="species:ncbi:9606">women</span>
ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women.
###end article-title 72
###begin article-title 73
###xml 90 95 <span type="species:ncbi:9606">women</span>
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.
###end article-title 73
###begin article-title 74
Non-secretor status is associated with female acute uncomplicated pyelonephritis.
###end article-title 74
###begin article-title 75
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.
###end article-title 75
###begin article-title 76
###xml 67 75 <span type="species:ncbi:9606">children</span>
P blood group and proneness to urinary tract infection in Japanese children.
###end article-title 76
###begin article-title 77
Interleukin-8 and CXCR1 receptor functional polymorphisms and susceptibility to acute pyelonephritis.
###end article-title 77
###begin article-title 78
A genetic basis of susceptibility to acute pyelonephritis.
###end article-title 78
###begin article-title 79
###xml 80 88 <span type="species:ncbi:9606">children</span>
Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children.
###end article-title 79
###begin article-title 80
###xml 154 162 <span type="species:ncbi:9606">children</span>
Heat shock protein 72 (HSPA1B) gene polymorphism and Toll-like receptor (TLR) 4 mutation are associated with increased risk of urinary tract infection in children.
###end article-title 80
###begin article-title 81
###xml 109 114 <span type="species:ncbi:9606">human</span>
Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart.
###end article-title 81
###begin article-title 82
###xml 43 51 <span type="species:ncbi:9606">children</span>
Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.
###end article-title 82
###begin article-title 83
###xml 73 78 <span type="species:ncbi:9606">women</span>
Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.
###end article-title 83
###begin article-title 84
Pathogen recognition and innate immunity.
###end article-title 84
###begin article-title 85
Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.
###end article-title 85
###begin article-title 86
Recognition of microorganisms and activation of the immune response.
###end article-title 86
###begin article-title 87
###xml 67 83 <span type="species:ncbi:562">Escherichia coli</span>
Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses.
###end article-title 87
###begin article-title 88
###xml 54 70 <span type="species:ncbi:562">Escherichia coli</span>
Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.
###end article-title 88
###begin article-title 89
###xml 40 56 <span type="species:ncbi:562">Escherichia coli</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract.
###end article-title 89
###begin article-title 90
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 51 67 <span type="species:ncbi:562">Escherichia coli</span>
Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection.
###end article-title 90
###begin article-title 91
Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local gram-negative infection.
###end article-title 91
###begin article-title 92
###xml 14 30 <span type="species:ncbi:562">Escherichia coli</span>
Uropathogenic Escherichia coli as a model of host-parasite interaction.
###end article-title 92
###begin article-title 93
A toll-like receptor that prevents infection by uropathogenic bacteria.
###end article-title 93
###begin article-title 94
###xml 67 73 <span type="species:ncbi:9606">humans</span>
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans.
###end article-title 94
###begin article-title 95
A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' Disease.
###end article-title 95
###begin article-title 96
A polymorphism in toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis.
###end article-title 96
###begin article-title 97
###xml 9 14 <span type="species:ncbi:9606">human</span>
A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
###end article-title 97
###begin article-title 98
Cutting Edge: A Common Polymorphism Impairs Cell Surface Trafficking and Functional Responses of TLR1 but Protects against Leprosy.
###end article-title 98
###begin article-title 99
A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis.
###end article-title 99
###begin article-title 100
###xml 55 60 <span type="species:ncbi:9606">human</span>
Toll-like receptor polymorphisms and susceptibility to human disease.
###end article-title 100
###begin article-title 101
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TLR1 Deficiency Is Associated with Impaired Mycobacterial Signaling and Protection from Leprosy Reversal Reaction.
###end article-title 101
###begin article-title 102
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 80 100 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease.
###end article-title 102
###begin article-title 103
Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.
###end article-title 103
###begin article-title 104
Consed: a graphical tool for sequence finishing.
###end article-title 104
###begin article-title 105
Multilocus LD measure and tagging SNP selection with generalized mutual information.
###end article-title 105
###begin article-title 106
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease.
###end article-title 106
###begin article-title 107
MALDI-TOF mass spectrometry-based SNP genotyping.
###end article-title 107
###begin article-title 108
A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.
###end article-title 108
###begin article-title 109
###xml 73 78 <span type="species:ncbi:9606">human</span>
Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease.
###end article-title 109
###begin article-title 110
Discerning the ancestry of European Americans in genetic association studies.
###end article-title 110
###begin article-title 111
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Evidence for separate genetic defects in C3H/HeJ and C3HeB/FeJ mice, that affect susceptibility to gram-negative infections.
###end article-title 111
###begin article-title 112
###xml 34 50 <span type="species:ncbi:562">Escherichia coli</span>
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains.
###end article-title 112
###begin article-title 113
###xml 62 67 <span type="species:ncbi:9606">human</span>
Toll-like receptor 4 expression and cytokine responses in the human urinary tract mucosa.
###end article-title 113
###begin article-title 114
Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells.
###end article-title 114
###begin article-title 115
###xml 17 22 <span type="species:ncbi:10090">mouse</span>
###xml 56 63 <span type="species:ncbi:562">E. coli</span>
Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide.
###end article-title 115
###begin article-title 116
###xml 120 136 <span type="species:ncbi:562">Escherichia coli</span>
CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli.
###end article-title 116
###begin article-title 117
###xml 32 36 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Bladder injury model induced in rats by exposure to protamine sulfate followed by bacterial endotoxin.
###end article-title 117
###begin p 118
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 118
###begin p 119
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grant NIH/NIDDK #1 PO1 DK53369-06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 119

